Diagnosis of Bladder Pain Syndrome / Interstitial Cystitis

Cantonal Hospital, Frauenfeld1 site in 1 country300 target enrollmentDecember 2004

ConditionsBladder Pain Syndrome Interstitial Cystitis Overactive Bladder

Overview

Phase: N/A
Intervention: Not specified
Conditions: Bladder Pain Syndrome
Sponsor: Cantonal Hospital, Frauenfeld
Enrollment: 300
Locations: 1
Primary Endpoint: Identification of new diagnostic markers for BPS/IC
Status: Completed
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

To identify new, simple and reliable biomarkers for bladder pain syndrome/interstitial cystitis (BPS/IC) for diagnosis of this disease.

Detailed Description

Collection and analyses of bladder biopsies, bladder washings, blood and urine samples of patients with bladder pain syndrome/interstitial cystitis (BPS/IC), overactive bladder syndrome (OAB) and bladder-healthy controls. Analyses include ELISA, RT-qPCR, DNA sequencing, and immunohistochemistry techniques. Differences between patient groups are statistically evaluated.

Registry

clinicaltrials.gov

Start Date

December 2004

End Date

July 2021

Last Updated

4 years ago

Study Type

Interventional

Study Design

Single Group

Sex

Female

Investigators

Sponsor

Cantonal Hospital, Frauenfeld

Responsible Party

Principal Investigator

Prof. Dr. Volker Viereck

Prof. Dr. med.

Cantonal Hospital, Frauenfeld

Eligibility Criteria

Inclusion Criteria

•patient with diagnosed BPS/IC, OAB or healthy controls
•included healthy controls must have another pelvic surgery planned (e.g. hysterectomy)
•being able to act and judge